Home   »   About Us   »   Suzanne Hendrix, PhD

Our people

Suzanne Hendrix, PhD

President, Pentara Corporation Salt Lake City, Utah

Dr. Hendrix has worked for the past 26 years as a biostatistician focusing on clinical trial research in many different indications. She has extensive experience designing clinical trials, writing statistical analysis plans, running analyses, writing statistical reports, interacting with the FDA and preparing manuscripts for publication. She is experienced at communicating statistical concepts in an understandable way, and has helped develop software for graphically understanding large complex datasets. For the past 14 years, she has specialized in statistical issues in Alzheimer's disease such as identifying appropriate outcomes, addressing measurement issues, demonstrating disease modification and optimizing clinical trial design and analysis. She has been on multiple advisory boards and expert panels addressing current issues in Alzheimer’s disease, and has interacted with the division of Neurology products at the FDA and with the EMA through scientific advice regarding these issues. She is currently president and owner of Pentara, a company that provides data management and statistical consultation to the pharmaceutical industry, academic groups and non-profit groups, primarily supporting clinical trial design and optimization in Alzheimer's disease. She has researched methods for discerning disease modification of treatments, and has proposed novel approaches to this problem. She is an active researcher in the Alzheimer’s disease field with over 100 publications and presentations.

  • Michael Fossel, MD, PhD

    Founder, President

  • Peter Rayson

    Founder, Chief Executive Officer

  • Mark Hodges

    Chief Operating Officer (COO)

  • Russell Swerdlow, MD

    Director of Alzheimer's Diease Center. Professor of Neurology, University of Kansas

  • Brian Kaspar, PhD

    Center for Gene Therapy, Nationwide Children's Hospital Ohio

  • Mimoun Azzouz, PhD

    Chair Translational Neuroscience University of Sheffield, UK

  • Joseph Araujo, PhD

    CEO and President, InterVivo Solutions